News Daily News Lotus Edge TAVR Device Recalled and Discontinued Worldwide Michael O'Riordan November 18, 2020
News Daily News Failure to Access Coronaries After TAVR Almost Exclusive to CoreValve Evolut Michael O'Riordan October 28, 2020
News Conference News TCT 2020 Acurate Neo Still Falls Short of Sapien 3 in SCOPE 1-Year Follow-up Michael O'Riordan October 23, 2020
News Conference News TCT 2020 Sapien 3 Stroke Rate Perplexes in 1-Year SOLVE-TAVI Results Michael O'Riordan October 16, 2020
News Conference News TCT 2020 Acurate Neo Fails to Match Results of CoreValve Evolut: SCOPE 2 Michael O'Riordan October 15, 2020
News Daily News TAVR Delays During Pandemic’s Peak Led to Hospitalizations, Deaths Michael O'Riordan September 30, 2020
News Daily News Which TAVR Device Is Best? Review Tackles Optimal Selection Michael O'Riordan September 09, 2020
News Conference News TVT 2020 Device Explants After TAVR Rare but Risky Michael O'Riordan June 24, 2020
News Conference News TVT 2020 Reduced Leaflet Motion After TAVR: No Link to Impaired Hemodynamics, Events Michael O'Riordan June 23, 2020
News Conference News TVT 2020 Sapien 3 in Intermediate Risk: Death or Stroke Similar to SAVR at 5 Years Michael O'Riordan June 22, 2020
News Daily News TAVR Bests Surgical Redo for Failed Bioprostheses: Early Data Michael O'Riordan June 01, 2020
News Daily News Good Results With Next-Gen, Self-Expanding TAVR in Bicuspid Valves Michael O'Riordan May 27, 2020
News Conference News HRS 2020 Permanent Conduction-System Pacing After TAVR? Don’t ‘Diss the His’ Michael O'Riordan May 21, 2020
News Daily News LV Mass Regression After TAVR Linked to Better Long-term Outcomes Michael O'Riordan May 13, 2020
News Conference News ACC 2020 New Patient-Focused TAVR Quality Score Rolling Out to US Hospitals Michael O'Riordan April 06, 2020
News Conference News ACC 2020 Early Data Support TAVR in Bicuspid Valves, but Questions Remain Michael O'Riordan March 29, 2020
News Conference News ACC 2020 Lower Risk of Death With Conscious Sedation in TAVR: TVT Registry Michael O'Riordan March 19, 2020
News Daily News Preventing TAVR Obstruction of Coronary Arteries Remains a Challenge Michael O'Riordan March 17, 2020
News Daily News Late Cerebrovascular Events ‘Devastating’ in TAVR-Treated Patients Michael O'Riordan March 11, 2020
News Features Trial by Twitter: How a 280-Character Count Is Reshaping Cardiology Michael O'Riordan March 03, 2020